OSI Pharmaceuticals LLC v. Roxane Laboratories INC.
1:12-cv-00644
Overview
Parties
Defendant
Plaintiff
Genentech Inc Operating Company
Represented By
1 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Pfizer Inc. Operating Company
Represented By
1 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
OSI Pharmaceuticals LLC Operating Company
Represented By
1 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 7,087,613 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 16,490,799 P | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 19,319,100 P | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 20,642,000 P | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 6,900,221 B1 | US Continuation / Sibling | View Official Patent → |
Apotex, Inc. et al. v. OSI Pharmaceuticals, LLC et al.
OSI Pharmaceuticals, LLC v. Apotex Inc.
OSI Pharmaceuticals LLC v. Roxane Laboratories Inc.
OSI Pharmaceuticals LLC v. Roxane Laboratories Inc.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7087613
Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
|
Filed: 2004-11-18
Issued: 2006-08-08
|
Expired (Term Ended)
Expires: 2024-11-18
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
1
Dispositive
1
Granted
0
Denied
0
Pending / Review
1
Motions by Category
Key Dispositive Motions & Rulings